Japan Pharma: Core Coverage Investment Thesis and Valuations (I/III)
Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...
298 Views
Japan: Most Overbought and Oversold - Relative Price Score Update - Companies
RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the current...
447 Views
Encouraging NS-065 Top-Line Data, However, Uptravi’s Global Ramp-Up Remains the Key
We reiterate our “Overweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings. Our rating is subject to Uptravi’s...
141 Views
Nippon Shinyaku Stock up 6% Provides Profit Booking Opportunity
Announcement – Nippon Shinyaku Co Ltd (4516 JP), on May 10, 2018, announced that presentations on NS-065/ NCNP-01 will be given at 2018 New...
94 Views
Nippon Shinyaku FY17 Earnings - First Glance
Nippon Shinyaku Co Ltd (4516 JP) reported FY17 results on May 09, 2018 Brisk global uptake of recently launched Uptravi and Zalutia drove FY17...
92 Views